Sakura Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 6 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.04 Cr
as on 10-12-2024
- Revenue 35.49%
(FY 2021)
- Profit 152.12%
(FY 2021)
- Ebitda 96.99%
(FY 2021)
- Net Worth 264.31%
(FY 2021)
- Total Assets 13.04%
(FY 2021)
About Sakura Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.04 Cr.
Abhishek Kapoor, Jolly Benjamin, and Kamlesh Sah serve as directors at the Company.
- CIN/LLPIN
U93000UR2018PTC009324
- Company No.
009324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Almora, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sakura Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Kapoor  | Director | 20-Dec-2018 | Current |
| Jolly Benjamin | Director | 20-Dec-2018 | Current |
| Kamlesh Sah | Director | 19-Jul-2019 | Current |
Financial Performance of Sakura Healthcare.
Sakura Healthcare Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 35.49% increase. The company also saw a substantial improvement in profitability, with a 152.12% increase in profit. The company's net worth Soared by an impressive increase of 264.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sakura Healthcare?
In 2021, Sakura Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
P.I. Prestige International India Private LimitedActive 7 years 7 monthsKamlesh Sah is a mutual person
Nature Health Biosciences Private LimitedActive 3 years 10 monthsAbhishek Kapoor is a mutual person
- Sakura Labs Private LimitedActive 2 years 8 months
Abhishek Kapoor and Jolly Benjamin are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Sep 2024 | ₹1.81 M | Open |
Hdfc Bank Limited Creation Date: 14 Aug 2023 | ₹1.51 Cr | Open |
Hdfc Bank Limited Creation Date: 31 Aug 2021 | ₹3.50 M | Open |
How Many Employees Work at Sakura Healthcare?
Unlock and access historical data on people associated with Sakura Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sakura Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sakura Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
